简短同伴自我管理干预对罕见慢性病患者疗效的随机临床试验
这项在德国开展的2组随机临床试验纳入89例因罕见病功能受限的成人患者,比较6周自助书加电话同伴咨询联合常规照护与单独常规照护的疗效。干预后6个月,干预组疾病接受度(ICQ)显著高于对照组,平均差异-1.47(95%CI,-2.63至-0.31;
要点
- 6周自助书加电话同伴咨询联合常规照护可改善罕见慢性病患者的疾病接受度。
- 部分应对策略、社会支持和心理生活质量等次要结局也显著优于对照组。
核心结论
- 自助书加同伴咨询的简短跨诊断干预可提高罕见慢性病患者对疾病的接受度。
- 自我管理和同伴支持可有效回应罕见病患者的独特照护需求。
研究设计与样本
- 2组随机临床试验,2017年10月5日至2019年7月12日在德国通过专科门诊和患者组织招募,患者居家参与。
- 纳入连续成人患者,病种为1型神经纤维瘤病、Marfan综合征、原发性硬化性胆管炎和肺动脉高压,且因病功能受限。
- 排除危及生命的健康状态和正在接受心理治疗者;筛查143例,排除54例,随机89例(干预组45例,对照组44例),87例(98%)完成6个月随访。
- 采用意向性治疗原则分析,数据清理和分析于2019年4月25日至2020年2月13日进行。
- 干预为6周自助书加电话同伴咨询联合常规照护,对照组仅常规照护;同伴咨询师接受培训、结构化咨询指南和监督。
主要发现
- 89例患者平均(SD)年龄46.3(14.9)岁,59例(66%)为女性,基线变量组间无差异,干预组全部完成干预。
- 包括不同应对策略、社会支持和心理生活质量在内的若干次要结局在干预后显著高于对照组。
关键数值与推荐
- 主要结局为干预后6个月疾病接受度,采用疾病认知问卷(ICQ)评估,平均总分范围0至18,分值越高表示接受度越高。
- 次要结局包括自报应对策略(健康教育影响问卷)、疾病认知(ICQ和疾病感知问卷)、抑郁严重度(患者健康问卷9项抑郁量表)、焦虑严重度(广泛性焦虑障碍量表)、生活质量(12项简短健康调查)和社会支持(社会支持问卷)。
- 结局在干预前、干预后和6个月随访时评估。
临床怎么用
- 对因罕见慢性病功能受限的成人患者,可在常规照护基础上考虑增加自助书加电话同伴咨询的简短干预。
- 同伴咨询师需接受培训、结构化咨询指南和监督,以保障干预实施质量。
- 疗效在干预后6个月显现,临床随访评估可关注疾病接受度及应对策略、社会支持和心理生活质量的变化。
局限性
- 研究仅纳入1型神经纤维瘤病、Marfan综合征、原发性硬化性胆管炎和肺动脉高压四种罕见病且功能受限的成人患者,外推需谨慎。
- 排除危及生命健康状态和正在接受心理治疗者,样本量89例,可能限制对更广泛人群的推广。
- 干预效果在干预刚结束时未显现,仅在6个月随访时显著,短期疗效不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Patients coping with rare diseases need psychosocial support. OBJECTIVE: To evaluate the efficacy of a brief, transdiagnostic, peer-delivered intervention for patients with rare diseases in addition to care as usual (CAU) compared with CAU only. DESIGN, SETTING, AND PARTICIPANTS: In this 2-group randomized clinical trial conducted from October 5, 2017, to July 12, 2019, patients were recruited via specialized clinics and patient organizations across Germany and participated from home. The study included consecutive adult patients with neurofibromatosis type 1, Marfan syndrome, primary sclerosing cholangitis, and pulmonary arterial hypertension who have limited functionality because of the disease. Exclusion criteria were a life-threatening health status and ongoing psychotherapeutic treatment. Of 143 patients screened for eligibility with a semistructured telephone interview, 54 were excluded, and 89 were randomized: 45 patients were randomly allocated to the peer-delivered intervention group, and 44 to the control group; 87 patients (98%) completed the 6-month follow-up assessment. The analysis was performed using an intention-to-treat principle. Data cleansing and analysis were conducted between April 25, 2019, and February 13, 2020. INTERVENTIONS: The 6-week intervention consisted of a self-help book and telephone-based peer counseling in addition to CAU. The control group received CAU alone. Peer counselors received training, structured consultation guidelines, and supervision. MAIN OUTCOMES AND MEASURES: The primary outcome was acceptance of the disease as assessed using the Illness Cognition Questionnaire (ICQ; mean sum scores range from 0 to 18, with higher values representing more acceptance) 6 months after the intervention. Secondary outcomes included self-reported coping strategies (Health Education Impact Questionnaire), illness cognition (ICQ and Illness Perception Questionnaire), depression severity (Patient Health Questionnaire 9-item depression scale), anxiety severity (Generalized Anxiety Disorder Scale), quality of life (12-Item Short-Form Health Survey), and social support (Social Support Questionnaire). Outcomes were assessed before the intervention, after the intervention, and at a 6-month follow-up. RESULTS: The mean (SD) age of the 89 participating patients was 46.3 (14.9) years; 59 (66%) were women. There were no group differences regarding baseline variables. All patients allocated to the intervention group completed the intervention. Six months after the intervention, but not directly after completing the program, the intervention group had significantly higher rates of acceptance (ICQ) of the disease (primary outcome) compared with the CAU group. Mean (SD) baseline ICQ scores were 9.61 (3.79) in the control group and 9.86 (3.40) in the intervention group. Mean (SE) ICQ scores at 6 months were 10.32 (0.42) for the control group and 11.79 (0.42) for the intervention group, with a significant mean difference of -1.47 (95% CI, -2.63 to -0.31; P = .01). Several secondary outcomes, including different coping strategies, social support, and mental quality of life, were significantly higher after the intervention compared with the control group. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, a self-help and peer counseling intervention improved patients' acceptance of their rare chronic diseases. Self-management and peer support can efficiently address the unique care needs of patients with rare diseases. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN13738704.
引用
- Depping MK, Uhlenbusch N, Härter M, et al. Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial. JAMA Psychiatry. 2021. PMID: 33625502. doi:10.1001/jamapsychiatry.2020.4783
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。